Emyria Limited is a clinical services and drug development company focused on improving patient outcomes in neuroscience and mental health via a unique business model:
Emyria Care: Deliver evidence-based and emerging therapies for mental health and other unmet needs across multiple sites (Empax Centres).
Emyria Data: Robust and ethically-sourced Real-World Data gathered with patients. Emyria Data is used to improve Emyria’s distinct therapy and drug development programs.
Emyria Drug Discovery: One of the world's largest libraries of unique MDMA-like compounds developed in partnership with the University of Western Australia for a range of mental health and select neuroscience indications.
Company Details
- Employees
- 11
- Address
- 661 Newcastle St, Leederville,western Australia 6007,australia
- Phone
- 1300 436 363
- in****@****ria.com
- Industry
- Mental Health Care
- NAICS
-
Offices of Mental Health Practitioners (except Physicians)
- Website
- emyria.com
- HQ
- Leederville, Western Australia
Emyria (Asx:emd) Questions
Emyria (Asx:Emd)'s helpline number is 1300 436 363
Emyria (Asx:Emd)'s website is emyria.com
Emyria (Asx:Emd)'s LinkedIn profile is https://au.linkedin.com/company/emyria
Emyria (Asx:Emd) has
11 employees.
View email and phone details for 11
employees at Emyria (Asx:Emd).
Emyria (Asx:Emd)'s industry is
Mental Health Care
Emyria (Asx:Emd)'s top competitors are
Linear Clinical Research,
Inoviq Ltd (Asx:iiq),
Omada Health,
Montu,
Strongroom Ai,
Little Green Pharma,
Inspiring Holdings Pty Ltd,
Xylo Bio,
Avive Health,
Reset Mind Sciences.
Emyria (Asx:Emd)'s support email address is info@emyria.com
Emyria (Asx:Emd)'s categories are Mental Health Care
